Martinez Bueno A, Molina MA, Fielding A, et al. Disruptive mutations in TP53 associate with survival benefit in a PARPi trial in ovarian cancer. ESMO 2017, abstract LBA42.
PET-scan toont effect van bevacizumab bij kinderen met diffuus intrinsiek ponsglioom
mei 2017 | Neuro-oncologie